BANOVIC, Marko, Bernard IUNG, Jozef BARTUNEK, Milika ASANIN, Branko BELESLIN, Bojan BIOCINA, Filip CASSELMAN, Mark da COSTA, Marek DEJA, Hrvoje GASPAROVIC, Petr KALA, Lois LABROUSSE, Zlatibor LONCAR, Jelena MARINKOVIC, Ivana NEDELJKOVIC, Milan NEDELJKOVIC, Peter NEMEC, Serge D. NIKOLIC, Michael PENCINA, Martin PENICKA, Arsen RISTIC, Faidal SHARIF, Guy Van CAMP, Marc VANDERHEYDEN, Wojtek WOJAKOWSKI a Svetozar PUTNIK. Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial. American Heart Journal. New York: Mosby Inc., 2016, roč. 174, "neuvedeno", s. 147-153. ISSN 0002-8703. Dostupné z: https://dx.doi.org/10.1016/j.ahj.2016.02.001. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1366699, author = {Banovic, Marko and Iung, Bernard and Bartunek, Jozef and Asanin, Milika and Beleslin, Branko and Biocina, Bojan and Casselman, Filip and Costa, Mark da and Deja, Marek and Gasparovic, Hrvoje and Kala, Petr and Labrousse, Lois and Loncar, Zlatibor and Marinkovic, Jelena and Nedeljkovic, Ivana and Nedeljkovic, Milan and Nemec, Peter and Nikolic, Serge D. and Pencina, Michael and Penicka, Martin and Ristic, Arsen and Sharif, Faidal and Camp, Guy Van and Vanderheyden, Marc and Wojakowski, Wojtek and Putnik, Svetozar}, article_location = {New York}, article_number = {"neuvedeno"}, doi = {http://dx.doi.org/10.1016/j.ahj.2016.02.001}, keywords = {VALVULAR HEART-DISEASE; BEFORE-SYMPTOM-ONSET; HIGH-RISK PATIENTS; NATURAL-HISTORY; CLINICAL-TRIALS; FOLLOW-UP; SURGERY; PATIENT; PROSTHESIS; SURVIVAL}, language = {eng}, issn = {0002-8703}, journal = {American Heart Journal}, title = {Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial}, volume = {174}, year = {2016} }
TY - JOUR ID - 1366699 AU - Banovic, Marko - Iung, Bernard - Bartunek, Jozef - Asanin, Milika - Beleslin, Branko - Biocina, Bojan - Casselman, Filip - Costa, Mark da - Deja, Marek - Gasparovic, Hrvoje - Kala, Petr - Labrousse, Lois - Loncar, Zlatibor - Marinkovic, Jelena - Nedeljkovic, Ivana - Nedeljkovic, Milan - Nemec, Peter - Nikolic, Serge D. - Pencina, Michael - Penicka, Martin - Ristic, Arsen - Sharif, Faidal - Camp, Guy Van - Vanderheyden, Marc - Wojakowski, Wojtek - Putnik, Svetozar PY - 2016 TI - Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial JF - American Heart Journal VL - 174 IS - "neuvedeno" SP - 147-153 EP - 147-153 PB - Mosby Inc. SN - 00028703 KW - VALVULAR HEART-DISEASE KW - BEFORE-SYMPTOM-ONSET KW - HIGH-RISK PATIENTS KW - NATURAL-HISTORY KW - CLINICAL-TRIALS KW - FOLLOW-UP KW - SURGERY KW - PATIENT KW - PROSTHESIS KW - SURVIVAL N2 - Aortic valve replacement (AVR) therapy is an obvious choice for symptomatic severe aortic stenosis (AS) patients as it improves symptoms, left ventricular function, and survival. The treatment decisions and indication for AVR in asymptomatic patients with severe AS and normal left ventricular ejection fraction are less well established and the subject of ongoing debate. Many efforts have been made to define the best treatment option in asymptomatic AS patients with normal left ventricular ejection fraction. Retrospective and observational data imply that elective AVR for asymptomatic severe AS may lead to improvement in outcomes in comparison to surgery performed after onset of symptoms. The AVATAR trial will aim to assess outcomes among asymptomatic AS patients randomized to either elective early AVR or medical management with vigilant follow-up. In the latter group, AVR would be delayed until either the onset of symptoms or changes in predefined echocardiographic parameters. To the best of the authors' knowledge, it will be the first large prospective, randomized, controlled, multicenter clinical trial that will evaluate the safety and efficacy of elective AVR in this specific group of patients. ER -
BANOVIC, Marko, Bernard IUNG, Jozef BARTUNEK, Milika ASANIN, Branko BELESLIN, Bojan BIOCINA, Filip CASSELMAN, Mark da COSTA, Marek DEJA, Hrvoje GASPAROVIC, Petr KALA, Lois LABROUSSE, Zlatibor LONCAR, Jelena MARINKOVIC, Ivana NEDELJKOVIC, Milan NEDELJKOVIC, Peter NEMEC, Serge D. NIKOLIC, Michael PENCINA, Martin PENICKA, Arsen RISTIC, Faidal SHARIF, Guy Van CAMP, Marc VANDERHEYDEN, Wojtek WOJAKOWSKI a Svetozar PUTNIK. Rationale and design of the Aortic Valve replAcemenT versus conservative treatment in Asymptomatic seveRe aortic stenosis (AVATAR trial): A randomized multicenter controlled event-driven trial. \textit{American Heart Journal}. New York: Mosby Inc., 2016, roč.~174, ''neuvedeno'', s.~147-153. ISSN~0002-8703. Dostupné z: https://dx.doi.org/10.1016/j.ahj.2016.02.001.
|